XCath Timeline

Events

• 2026-03-12 - Funding - XCath secures $30M Series C to advance neuro-endovascular surgical robotics - XCath announced a $30M Series C to support development and future commercialization of its endovascular surgical robot. The round was co-led by Crescent Enterprises and Dr. Fred Moll, chairman of XCath's board. The financing brought total capital raised… - source: businesswire.com
• 2025-11-12 - Deployment - XCath EVR robotic system performs first-in-human brain aneurysm procedures - XCath announced first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms at The Panama Clinic. The procedures marked only the second time a surgical robot had been used in an intracranial neurovascular intervention.… - source: finance.yahoo.com
• 2022-01-01 - Funding - XCath $24M Series B (Crescent Enterprises 2022 report) - XCath raised additional funding, bringing total capital raised to $24M; Crescent Enterprises cited the round in its 2022 sustainability report. The financing supported advancement of XCath's neuro-endovascular robotic platforms toward regulatory clearances… - source: crescententerprises.com